Literature DB >> 35713858

A Hybrid Protocol for Finding Novel Gene Targets for Various Diseases Using Microarray Expression Data Analysis and Text Mining.

Sharanya Manoharan1, Oviya Ramalakshmi Iyyappan2.   

Abstract

The advancement in technology for various scientific experiments and the amount of raw data produced from that is enormous, thus giving rise to various subsets of biologists working with genome, proteome, transcriptome, expression, pathway, and so on. This has led to exponential growth in scientific literature which is becoming beyond the means of manual curation and annotation for extracting information of importance. Microarray data are expression data, analysis of which results in a set of up/downregulated lists of genes that are functionally annotated to ascertain the biological meaning of genes. These genes are represented as vocabularies and/or Gene Ontology terms when associated with pathway enrichment analysis need relational and conceptual understanding to a disease. The chapter deals with a hybrid approach we designed for identifying novel drug-disease targets. Microarray data for muscular dystrophy is explored here as an example and text mining approaches are utilized with an aim to identify promisingly novel drug targets. Our main objective is to give a basic overview from a biologist's perspective for whom text mining approaches of data mining and information retrieval is fairly a new concept. The chapter aims to bridge the gap between biologist and computational text miners and bring about unison for a more informative research in a fast and time efficient manner.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Drug target; Drug target prediction; Gene enrichment; Gene expression analysis; Gene function analysis; Gene prediction; Information extraction; Text mining

Mesh:

Year:  2022        PMID: 35713858     DOI: 10.1007/978-1-0716-2305-3_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  33 in total

Review 1.  Computational approaches to disease-gene prediction: rationale, classification and successes.

Authors:  Rosario M Piro; Ferdinando Di Cunto
Journal:  FEBS J       Date:  2012-01-30       Impact factor: 5.542

2.  Trial watch: Phase II failures: 2008-2010.

Authors:  John Arrowsmith
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

Review 3.  The approved gene therapy drugs worldwide: from 1998 to 2019.

Authors:  Cui-Cui Ma; Zhen-Ling Wang; Ting Xu; Zhi-Yao He; Yu-Quan Wei
Journal:  Biotechnol Adv       Date:  2019-12-27       Impact factor: 14.227

4.  How to link ontologies and protein-protein interactions to literature: text-mining approaches and the BioCreative experience.

Authors:  Martin Krallinger; Florian Leitner; Miguel Vazquez; David Salgado; Christophe Marcelle; Mike Tyers; Alfonso Valencia; Andrew Chatr-aryamontri
Journal:  Database (Oxford)       Date:  2012-03-21       Impact factor: 3.451

Review 5.  A survey on the computational approaches to identify drug targets in the postgenomic era.

Authors:  Yan-Fen Dai; Xing-Ming Zhao
Journal:  Biomed Res Int       Date:  2015-04-28       Impact factor: 3.411

6.  Drug target ontology to classify and integrate drug discovery data.

Authors:  Yu Lin; Saurabh Mehta; Hande Küçük-McGinty; John Paul Turner; Dusica Vidovic; Michele Forlin; Amar Koleti; Dac-Trung Nguyen; Lars Juhl Jensen; Rajarshi Guha; Stephen L Mathias; Oleg Ursu; Vasileios Stathias; Jianbin Duan; Nooshin Nabizadeh; Caty Chung; Christopher Mader; Ubbo Visser; Jeremy J Yang; Cristian G Bologa; Tudor I Oprea; Stephan C Schürer
Journal:  J Biomed Semantics       Date:  2017-11-09

Review 7.  Genome editing for Duchenne muscular dystrophy: a glimpse of the future?

Authors:  Christian Kupatt; Alina Windisch; Alessandra Moretti; Eckhard Wolf; Wolfgang Wurst; Maggie C Walter
Journal:  Gene Ther       Date:  2021-02-02       Impact factor: 5.250

Review 8.  A comprehensive map of molecular drug targets.

Authors:  Rita Santos; Oleg Ursu; Anna Gaulton; A Patrícia Bento; Ramesh S Donadi; Cristian G Bologa; Anneli Karlsson; Bissan Al-Lazikani; Anne Hersey; Tudor I Oprea; John P Overington
Journal:  Nat Rev Drug Discov       Date:  2016-12-02       Impact factor: 84.694

9.  In silico prediction of novel therapeutic targets using gene-disease association data.

Authors:  Enrico Ferrero; Ian Dunham; Philippe Sanseau
Journal:  J Transl Med       Date:  2017-08-29       Impact factor: 5.531

Review 10.  Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy.

Authors:  Vratko Himič; Kay E Davies
Journal:  Eur J Hum Genet       Date:  2021-02-09       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.